• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Absorption, distribution, metabolism and excretion
Absorption, distribution, metabolism and excretion

... with natural compounds • Drug may have actions increased or decreased or changed • Individual variation genetically determined • May be several routes of metabolism • May not be what terminates drug action • May take place anywhere BUT liver is prime site • Not constant - can be changed by other dru ...
An analysis of drug induced Stevens-Johnson syndrome
An analysis of drug induced Stevens-Johnson syndrome

... the unknown agents, most of the drugs (11) were used for the treatment of fever, and were available as over the counter drugs. Majority (56) of the suspected drugs were stopped after reaction. The symptoms resolved in 42 cases, while in the remaining 14 patients the reaction continued unabated. The ...
Kishore Herbstman
Kishore Herbstman

... of different statins.11 Therefore, the choice of statin should ultimately be left to individual nations. To ensure safety, we recommended that patients seek medical care in the first year of treatment to be monitored for liver-function impairment and evaluated for rhabdomyolysis—adverse effects that ...
Comparing Osteoporosis Drugs
Comparing Osteoporosis Drugs

... The Consumer Reports Best Buy Drugs are in blue. We recommend these drugs because they work as well and are as safe as the other drugs, and they cost less. This symbol means that you might be able to get the drug at a low cost at large chain stores, like Costco, CVS, Kmart, Kroger, Sam’s Club, Targe ...
Questcor Finds Profit for Acthar Drug, at $28,000 a Vial
Questcor Finds Profit for Acthar Drug, at $28,000 a Vial

... In 1952, Armour won approval from the F.D.A. for H.P. Acthar Gel, or “highly purified” ACTH mixed with gelatin (another animal byproduct) to make it last longer in the body and require fewer injections. The label said the drug could be used to treat about 50 diseases. But by the 1980s, drug companie ...
April 2009, Number 04
April 2009, Number 04

... this product. For example, the combination of oral colchicine and probenacid is an FDA-approved drug. However, oral colchicine, as a single active ingredient, is an unapproved drug. The opposite of this is when 2 ingredients are FDA-approved separately but are being marketed in combination as an una ...
Ocular Pharmacology - Faculty of Medical and Health Sciences
Ocular Pharmacology - Faculty of Medical and Health Sciences

... contain surfactant(s)  local toxicity low stability  flocculation - coalescence - cracking high cost ...
CHOOSE THE SINGLE BEST ANSWER Matching. Match each of the
CHOOSE THE SINGLE BEST ANSWER Matching. Match each of the

... 6. Significant CNS drug penetration is seen in patients treated with A. Paclitaxel B. Mechlorethamine C. Daunorubicin D. Lomustine E. Teniposide 7. Which part of a prescription includes the name, strength and dosage form of the medication to be dispensed? A. Superscription. B. Inscription C. Subscri ...
Chapter Sixteen: Using Drugs Responsibly
Chapter Sixteen: Using Drugs Responsibly

... – Pharmaceutical companies market to doctors by “courting” them for business. – In the United States, pharmaceutical companies are also allowed to advertise directly to consumers through television and print media. ...
antimycobacterials
antimycobacterials

... tuberculosis—the leading cause worldwide of death from infection. Members of the genus Mycobacterium also cause leprosy, as well as, several tuberculosis-like human infections. Mycobacterial infections are intracellular and, generally, result in the formation of slow-growing granulomatous lesions th ...
100908 Gen Pharm (pt 2).
100908 Gen Pharm (pt 2).

... In disease, all systems are affected • The three systems can’t exist without each other • The actions of one impact the actions of the others – I.e., stress (nervous system) disrupts endocrine system which may respond with glucocorticoid production = suppressed immune response ...
What do you know about ECSTASY?
What do you know about ECSTASY?

... environment, but it becomes problematic when it’s intrinsically tied to drug use. It can set up a pattern of lifelong drug use. Drug use can lead to unsafe sex and HIV transmission.” – “Anything goes at a rave, and that’s both its strongest asset and its biggest flaw.” – Caitlin Ryan, clinical socia ...
Performance Enhancing Drugs Creatine Risks
Performance Enhancing Drugs Creatine Risks

... Supplements are considered food and not drugs by the FDA. This means supplement manufacturers are not required to conform to the same standards as drug manufacturers do. In some cases, supplements have been found to be contaminated with other substances, which may inadvertently lead to a positive te ...
Pharmacokinetic Phase
Pharmacokinetic Phase

... – tubocurarine, a paralyzing agent, is a fully ionized compound which will not reach the brain - a patient paralyzed with tubocurarine cannot move at all, but is fully awake ...
Pharmacology PT020D - Porterville College Home
Pharmacology PT020D - Porterville College Home

... Surface conditions ...
Express Results™ Online
Express Results™ Online

... results to help them make informed hiring and staffing decisions. When turnaround time is of the essence, Express Results™ Online provides a fast, accurate, electronically-driven drug testing solution. Negative drug screen results are available within minutes from the time of collection for up to 11 ...
press release
press release

... NicOx granted IND status for clinical testing of HCT 1026 in the US Sophia Antipolis – France, January 7, 2002- NicOx S.A. (Nouveau Marché: NICOX) today announced that its Investigational New Drug application (IND)* has been accepted by the US Food and Drug Administration (FDA) for the clinical test ...
NEWS YOU CAN USE 2015 08 UPD
NEWS YOU CAN USE 2015 08 UPD

... treatment of adults with heterozygous familial hypercholesterolemia or patients with clinical atheroschlerotic cardiovascular disease • It is to be used in addition to diet and ...
Chart compiled by Zak Fallows
Chart compiled by Zak Fallows

... Disclaimer: Do not misuse drugs. Do not use drugs for fun. Take drugs exactly as prescribed by a trustworthy doctor, and do not fear necessary prescription drugs because of terrible side effects on this chart (which, by the way, may be inapplicable or extremely rare in your case and have been consid ...
Management of Drug Formulary
Management of Drug Formulary

... -provides for a high level of flexibility -most of the time utilizes 3-tier benefit design, but can more ...
Phil Rowe Reader in pharmaceutical computing School of
Phil Rowe Reader in pharmaceutical computing School of

... A general tendency for liver metabolism to be less effective in the elderly, but it is not a major reduction and it is very variable between individuals. ...
the lowdown painkillers drug facts
the lowdown painkillers drug facts

... When recommended by a doctor, prescription drugs can be beneficial. But when abused, they can be very dangerous and addictive. At too high a dose, or when combined with alcohol, they can easily become deadly. Prescription drugs are medicines that are legitimately prescribed by doctors to treat a var ...
DOCX
DOCX

... BILL ANALYSIS ...
Polypharmacy in Older Adults: Risks and Strategies To
Polypharmacy in Older Adults: Risks and Strategies To

... Liperoti R, et al. J Clin Psych 2007;68: 929-34. ...
Bristol-Myers Squibb Pharmaceutical Research Institute
Bristol-Myers Squibb Pharmaceutical Research Institute

... Subcommittee. This letter stated that as a stakeholder, the NCCLS could help the FDA by setting breakpoints and quality control ranges of antimicrobial drugs, thereby saving FDA resources. F. Alan Andersen (President Elect of the NCCLS) presented the NCCLS stakeholder position. Representatives from ...
< 1 ... 115 116 117 118 119 120 121 122 123 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report